This post provides an analytical overview of the patentability of biotech inventions in the USA, focusing on statutory exclusions and major judicial decisions. It explains how US courts interpret the product of nature doctrine and outlines current limitations and developments in biotechnology patent law.
Read more about Patentability of Biotech Inventions in USA – Patentable Subject MatterTag: Diamond v Chakrabarty
Diamond v. Chakrabarty, 447 U.S. 303 (1980)
The Supreme Court in Diamond v. Chakrabarty held that human-made microorganisms are patentable under Section 101 of the Patent Act. The case clarified that patent eligibility depends on human ingenuity rather than the living or nonliving status of the invention.
Read more about Diamond v. Chakrabarty, 447 U.S. 303 (1980)